• University of Pennsylvania Featured PhD Programmes
  • Aberdeen University Featured PhD Programmes
  • University of Cambridge Featured PhD Programmes
  • University of Tasmania Featured PhD Programmes
  • Staffordshire University Featured PhD Programmes
University of Tasmania Featured PhD Programmes
Imperial College London Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
EPSRC Featured PhD Programmes
University of Reading Featured PhD Programmes
EPSRC - Engineering and Physical Sciences Research Council

EPSRC Systems Approaches to Biomedical Sciences

Biomedical Sciences

EPSRC and MRC Systems Approaches to Biomedical Science CDT

This programme is now full. Please check back in the next few weeks.

We are looking for graduates who want to make an impact in the exciting and highly interdisciplinary field of biomedical research. This unique and pioneering 4-year PhD programme provides comprehensive training to graduates primarily from the physical and life sciences who wish to undertake research careers at the industrial interface in this exciting new interdisciplinary field. We train future innovators and research leaders who will pioneer major advances in biomedical science underpinning the development of novel therapies and drugs. Each of our students will gain the broad skillset needed to confront current and future biomedical research challenges in our three themes:

  • Computational and structural approaches underpinning drug discovery - physical and structural study of biomolecules, chemoinformatics, bioinformatics and synthetic biology.
  • Data driven drug discovery - data handling, probabilistic (statistical) models, high performance computing.
  • Physiological modelling - advanced mathematical and computational methods, in particular looking at techniques spanning physical processes and spatio-temporal scales.

The programme is an open collaboration between Oxford University and 15 industrial partners; AstraZeneca, Diamond Light Source, e-Therapeutics, Evotec, GE Healthcare, GlaxoSmithKline, Hoffmann La Roche, InhibOx, Lilly UK, MedImmune, Moffitt Cancer Center, Novartis, Pfizer, Structural Genomics Consortium and UCB.

This unique and pioneering 4-year PhD programme provides comprehensive training to graduates

A major advantage of this programme is that the choice of PhD project is not made until after the completion of two terms of taught modules covering the breadth of scientific knowledge and cutting-edge techniques needed to carry out successful research, followed by two short research projects with prospective PhD academic and industry supervisors, situated within groups across the University. Our students are then empowered to make a fully informed choice of substantive research project.

We invite applications from students from the physical and life sciences who have received, or are on target to achieve, a strong 2:1 degree or above.

Full studentships are available for home and EU students (RCUK eligibility criteria apply) and two fully funded international studentships are available for the forthcoming academic year.

Full details of the programme and how to apply can be found at:


Please contact us directly for information on closing dates.

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.
Email Sent
Share this page:

Cookie Policy    X